Effect of HDL and atherogenic lipoproteins on formation of O2- and renin release in juxtaglomerular cells

Kidney International

Volumn 51, Issue 1, 1997, Pages 253-260

  Galle, Jan ^a   Heinloth, Alexandra ^a   Schwedler, Susanne ^a   Wanner, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SUPEROXIDE;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; CELL CULTURE; CONTROLLED STUDY; FEMALE; JUXTAGLOMERULAR CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENIN RELEASE;

EID: 0031058574     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.30     Document Type: Article

References (36)

1. HACKENTHAL E, PAUL M, GANTEN D, TAUGNER R: Morphology, physiology, and molecular biology of renin secretion. Physiol Rev 70:1067-1116, 1990
2. GALLE J, STUNZ P, SCHOLLMEYER P, WANNER C: Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells. Kidney Int 47:45-52, 1995
3. GALLE J, HERZOG C, SCHOLLMEYER P, WANNER C: Oxygen-derived radicals stimulate renin release of isolated juxtaglomerular cells. FEBS Lett 351:314-316, 1994
4. OHARA Y, PETERSON TE, HARRISON DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546-2551, 1993
5. GALLE J, BENGEN J, SCHOLLMEYER P, WANNER C: Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a) - Role of oxygen-derived radicals. Circulation 92:1582-1589, 1995
6. MATSUDA Y, HIRATA K, INOUE N, SUEMATSU M, KAWASHIMA S, AKITA H, YOKOYAMA M: High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ Res 72:1103-1109, 1993
7. HESSLER JR, ROBERTSON AL, CHISOLM JR, CHISOLM GM: LDL induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32:213-229, 1979
8. MEHTA JL, CHEN LY: Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets. J Lab Clin Med 127:287-295, 1996
9. GALLE J, BENGEN J, SCHOLLMEYER P, WANNER C: Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: Prevention by high density lipoprotein. Eur J Pharmacol 265:111-115, 1994
10. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with phenol reagent. J Biol Chem 193:265-275, 1951
11. JANERO DR: Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Rad Biol Med 9:515-540, 1990
12. RIGHTSEL WA, OKAMURA T, INAGAMI T, PITCOCK JA, TAKII Y, BROOKS B, BROWN P, MUIRHEAD EE: Juxtaglomerular cells grown as monolayer cell culture contain renin, angiotensin-I converting enzyme, and angiotensins I and II/III. Circ Res 50:822-829, 1982
13. VAN GELDER BF, SLATER EC: The extinction coefficient of cytochrome c. Biochim Biophys Acta 58:593-595, 1962
14. STEINBERG D, PARTHASARATHY S, CAREW TE, KHOO JC, WITZTUM JL: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915-924, 1989
15. REAVEN PD: Mechanisms of atherosclerosis: Role of LDL oxidation. Adv Exper Med Biol 366:113-128, 1994
16. WILLIAMS RR, HOPKINS PN, HUNT SC, SCHUMACHER MC, ELBEIN SC, WILSON DE, STULTS BM, WU LL, HASSTEDT SJ, LALOUEL J-M: Familial dyslipidaemic hypertension and other multiple metabolic syndromes. Ann Med 24:469-475, 1992
17. SAMUELSSON O, ATTMAN P, O, KNIGHT GIBSON C, KRON B, LARSSON R, MULEC H, WEISS L, ALAUPOVIC P: Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant 9:1580-1585, 1994
18. ATTMAN PO, ALAUPOVIC P, TAVELLA M, KNIGHT-GIBSON C: Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Nephrol Dial Transplant 11:63-69, 1996
19. ATTMAN P-O, SAMUELSSON O, ALAUPOVIC P: Lipoprotein metabolism and renal failure. Am J Kidney Dis 21:573-592, 1993
20. WANNER C, RADER D, BARTENS W, KRÄMER J, BREWER HB, SCHOLLMEYER P, WIELAND H: Elevated lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med 119:263-269, 1993
21. ICHIKAWA I, KIYAMA S, YOSHIOKA T: Renal antioxidant enzymes: Their regulation and function. Kidney Int 45:1-9, 1994
22. RUBANYI GM, VANHOUTTE PM: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250: H822-H827, 1986
23. PRYOR WA, SQUADRITO GL: The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide. Am J Physiol 268:L699-L722, 1995
24. MÜGGE A, BRANDES RP, BÖGER RH, DWENGER A, BODE-BÖGER S, KIENKE S, FRÖLICH JC, LICHTLEN PR: Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 24:994-998, 1994
25. HANSEN PR, KHARAZMI AK, JAUHIAINEN M, EHNHOLM C: Induction of free radical generation in human monocytes by lipoprotein(a). Eur J Clin Invest 24:497-499, 1994
26. 2 Produktion in isolierten Glomeruli. Nieren-und Hochdruckkrankheiten 24:532, 1995
27. PARTHASARATHY S, STEINBRECHER U, BARNETT J, WITZTUM JL, STEINBERG D: Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA 82:3000-3004, 1985
28. YOKOYAMA M, HIRATA K, MIYAKE R, AKITA H, ISHIKAWA Y, FUKUZAKI H: Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun 168:301-308, 1990
29. ESTERBAUER H, JÜRGENS G, QUEHENBERGER O, KOLLER E: Autoxidation of human low density lipoprotein: Loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 28:495-509, 1987
30. OHARA Y, PETERSON TE, ZHENG B, KUO JF, HARRISON DG: Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb 14:1007-1013, 1994
31. BARAJAS L: Anatomy of the juxtaglomerular apparatus. Am J Physiol 237:F333-F343, 1979
32. GRIENDLING KK, MINIERI CA, OLLERENSHAW JD, ALEXANDER RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148, 1994
33. GALLE J, ÖCHSLEN M, SCHOLLMEYER P, WANNER C: Oxidized lipoproteins inhibit endothelium-dependent vasodilation: Effects of pressure and high-density lipoprotein. Hypertension 23:556-564, 1994
34. MEHTA JL, BRYANT JL JR, MEHTA P: Reduction of nitric oxide synthase activity in human neutrophils by oxidized low-density lipoproteins - Reversal of the effect of oxidized low-density lipoproteins by high-density lipoproteins and L-arginine. Biochem Pharmacol 50:1181-1185, 1995
35. WATSON AD, BERLINER JA, HAMA SY, LA DU BN, FAULL KF, FOGELMAN AM, NAVAB M: Protective effect of high density lipoprotein associated paraoxonase - Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Ivest 96:2882-2891, 1995
36. CHRISTISON JK, RYE KA, STOCKER R: Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein. J Lipid Res 36:2017-2026, 1995